BHD protects against cerebral ischemic injury by modulating the S1P/S1PR1/PI3K/Akt signaling pathway, reducing SphK1 levels, and increasing SphK2 along with downstream protective proteins. This supports BHD as a potential treatment for ischemic stroke. The gene discussed is AKT1; the disease is ischemic stroke.